All Articles

Farmmi Inc. just raised $3 million, but the real story is the 80% discount and massive shareholder dilution. A look at the true cost of staying afloat.

Partnership Mastermind appoints Jen Kalant as CPO to fix a widespread 'execution problem.' As companies leave revenue on the table, her mission is to turn partner potential into profit.

Premium Income Corp. raises $70M in a bold overnight offering. What does this move, backed by Canada's big banks, mean for your portfolio and market stability?

Scutum's integration of a 40-year-old security firm is no simple buyout. It's the latest move in a strategy to dominate the North American market with AI.

In the wake of a national bullying scandal, a new AI app promises to read kids' texts. But is this digital surveillance the answer or a new problem?

Once a quiet niche, the wAIHA market is now a battleground for J&J, Sanofi, and Novartis, with a 14.4% growth forecast and a new class of drugs.

Scott Kirby's 'Executive of the Year' award isn't just for surviving turbulence. It's for a high-risk, high-reward strategy that's reshaping United's future.

HW Staffing's acquisition of TPi Staffing isn't just a deal; it's a strategic blueprint for the future of talent acquisition in a consolidating market.

UFC GYM's new PWR Clinics signal a tectonic shift in the wellness industry. Is this the future of fitness or a high-stakes bet on a regulatory minefield?

A new high-tech facility in St. Thomas, Ontario, will turn sewage into revenue and green energy. But as it supports a new industrial boom, it faces tough questions.

A new report reveals a massive strategic shift in obesity care. Pharma giants are pouring billions into FGF21, a new drug class aiming beyond weight loss.

A multi-billion dollar deal for Saab's GlobalEye spy planes signals a profound strategic shift for Canada, deepening ties with Sweden and fortifying Arctic sovereignty.

Micron links its semiconductor ambitions to a new federal savings plan, investing $250M in 'Trump Accounts.' Is this the future of workforce development?

Post-pandemic recovery in early reading has hit a wall. New data reveals a critical plateau, forcing a hard look at systemic flaws and data-driven solutions.

With its $340M purchase, Empower doubles down on integrated solutions, while Milliman pivots to AI and consulting. What does this mean for the industry?

Beyond a simple conference, Tsingke Biotech's recent salon was a strategic play to position itself as the linchpin in China's shift to biotech innovation.

ManageEngine launches its developer Marketplace, entering a field dominated by giants. Can its 'symbiotic' model and strict security governance set it apart?

A state-of-the-art cinema is for sale. More than a transaction, it’s a referendum on the future of suburban town centers and their anchor tenants.

A $23 pocket device claims to kill bug bite itch with heat. We go beyond the hype to analyze the science, the market, and the real-world trade-off.

Mitlin Financial's Lawrence Sprung is a finalist for two prestigious 'Wealthies' awards. His secret? A 'JOY-driven' philosophy that's challenging the industry.